Related news from
Tue, 16 Apr 2024 11:00:00 +0000	Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024 ALACHUA, Fla. and TAMPA, Fla., April 16, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that it will report first quarter 2024 financial results on Thursday, May 2, 2024, before the market opens. Axogen management will host an investment-community conference call and webcast at 8 a.m. ET following the release. Investors interested in participating in the conference call
Thu, 04 Apr 2024 12:01:54 +0000	Analysts Expect Breakeven For AxoGen, Inc. (NASDAQ:AXGN) Before Long AxoGen, Inc. ( NASDAQ:AXGN ) is possibly approaching a major achievement in its business, so we would like to shine...
Sat, 09 Mar 2024 04:55:49 +0000	Director Gregory Freitag Sells 25,000 Shares of Axogen Inc (AXGN) Director Gregory Freitag has sold 25,000 shares of Axogen Inc (NASDAQ:AXGN) on March 7, 2024, according to a recent SEC Filing.
Fri, 08 Mar 2024 10:37:15 +0000	US$13.80 - That's What Analysts Think AxoGen, Inc. (NASDAQ:AXGN) Is Worth After These Results There's been a notable change in appetite for AxoGen, Inc. ( NASDAQ:AXGN ) shares in the week since its full-year...
Wed, 06 Mar 2024 13:20:43 +0000	AxoGen, Inc. (NASDAQ:AXGN) Q4 2023 Earnings Call Transcript AxoGen, Inc. (NASDAQ:AXGN) Q4 2023 Earnings Call Transcript March 5, 2024 AxoGen, Inc. beats earnings expectations. Reported EPS is $-0.06, expectations were $-0.09. AXGN isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello, and welcome to the AxoGen, Inc. 2023 […]
Wed, 06 Mar 2024 12:37:47 +0000	AxoGen Full Year 2023 Earnings: Beats Expectations AxoGen ( NASDAQ:AXGN ) Full Year 2023 Results Key Financial Results Revenue: US$159.0m (up 15% from FY 2022). Net loss...
Wed, 06 Mar 2024 02:27:07 +0000	Q4 2023 AxoGen Inc Earnings Call Q4 2023 AxoGen Inc Earnings Call
Tue, 05 Mar 2024 12:31:50 +0000	Axogen Inc (AXGN) Reports Growth in Revenue and Reduction in Net Loss for Q4 and Full-Year 2023 Company Sees Increased Sales Across Core Segments and Continues to Innovate in Nerve Repair Market
Tue, 05 Mar 2024 12:00:00 +0000	Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial Results ALACHUA, Fla. and TAMPA, Fla., March 05, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today reported financial results and business highlights for the fourth quarter and full-year ended December 31, 2023. Fourth Quarter 2023 Financial Results and Business Highlights Fourth quarter revenue was $42.9 million, an 18.7% increase compared to the fourth quarter of 2022.The Company estimate
Tue, 05 Mar 2024 09:43:00 +0000	Zacks.com featured highlights Protagonist Therapeutics, AxoGen, Western Digital and Phunware Protagonist Therapeutics, AxoGen, Western Digital and Phunware have been highlighted in this Screen of The Week article.
Mon, 04 Mar 2024 22:20:04 +0000	Ekso Bionics (EKSO) Reports Q4 Loss, Tops Revenue Estimates Ekso Bionics (EKSO) delivered earnings and revenue surprises of -100% and 0.98%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Wed, 28 Feb 2024 13:50:08 +0000	AxoGen (AXGN) Is a Great Choice for 'Trend' Investors, Here's Why AxoGen (AXGN) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
Mon, 26 Feb 2024 14:15:12 +0000	AxoGen, Inc. (AXGN) Hit a 52 Week High, Can the Run Continue? AxoGen (AXGN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Tue, 20 Feb 2024 10:06:00 +0000	Zacks.com featured highlights AxoGen, Western Digital and Gen Digital AxoGen, Western Digital and Gen Digital have been highlighted in this Screen of The Week article.
Fri, 16 Feb 2024 11:08:00 +0000	3 Best Stocks to Buy for Remarkable Earnings Acceleration Invest in stocks such as AxoGen (AXGN), Western Digital (WDC) and Gen Digital (GEN) as of now for superb earnings acceleration.
Tue, 13 Feb 2024 21:30:00 +0000	Axogen, Inc. to Report 2023 Fourth Quarter and Full-Year Financial Results on March 5, 2024 ALACHUA, Fla. and TAMPA, Fla., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that it will report 2023 fourth quarter and full-year financial results on Tuesday, March 5, 2024, before the market opens. Axogen management will host an investment-community conference call and webcast at 8 a.m. ET following the release. Investors interested in participating in the
Mon, 12 Feb 2024 13:50:05 +0000	Here's Why Momentum in AxoGen (AXGN) Should Keep going If you are looking for stocks that are well positioned to maintain their recent uptrend, AxoGen (AXGN) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
Tue, 06 Feb 2024 14:40:08 +0000	Is AxoGen (AXGN) Stock Outpacing Its Medical Peers This Year? Here is how AxoGen (AXGN) and Boston Scientific (BSX) have performed compared to their sector so far this year.
Fri, 02 Feb 2024 21:15:00 +0000	Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) ALACHUA, Fla. and TAMPA, Fla., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced making Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) in connection with the employment and appointment of John Manning to the position of Area Vice President of Sales. Mr. Manning will report to Doris Quackenbush, Vice President of Sales. In connection with the commencement o
Tue, 30 Jan 2024 13:43:00 +0000	Zacks.com featured highlights include AxoGen, Western Digital, Accolade and Credo Technology Group AxoGen, Western Digital, Accolade and Credo Technology Group are part of the Screen of the Week article.